{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:46:13Z","timestamp":1785732373681,"version":"3.56.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The Progestin-Primed Ovarian Stimulation (PPOS) protocol with a freeze-all strategy is increasingly used for diminished ovarian reserve (DOR) patients. While growth hormone (GH) and Kuntai capsule are proposed adjuvants, their efficacy in this specific context remains unclear. This study aimed to determine whether pretreatment with these adjuvants improves live birth rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study (2015-2025) included 2, 969 DOR patients undergoing PPOS cycles. Participants were stratified into control (n=1, 665), Kuntai capsule (n=524), and GH (n=778) groups. Propensity score matching (1:1:1) balanced baseline characteristics, yielding 439 patients per group. The primary outcome was oocyte yield; secondary outcomes included embryological parameters, biochemical pregnancy, clinical pregnancy, and live birth. Generalized estimating equations controlled for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GH significantly enhanced ovarian response versus control: higher peak E\n                      <jats:sub>2<\/jats:sub>\n                      (607 vs. 518 pg\/mL, p&amp;lt;0.001), increased oocyte yield (3.0 vs. 2.0, p&amp;lt;0.001), and more available embryos (2.0 vs. 1.0, p=0.002). Biochemical pregnancy was higher with GH (67.4% vs. 57.3%, p=0.006). However, clinical pregnancy (45.7% vs. 44.5%) and live birth rates (27.8% vs. 28.2%) were comparable (p&amp;gt;0.05). GEE confirmed GH was not a predictor of live birth (aOR 0.85, 95% CI 0.54-1.33). Kuntai capsule showed no significant improvement in any ovarian response, embryo quality, or clinical outcomes, including live birth (27.0% vs. 28.2%, p&amp;gt;0.05). Multivariate analysis identified advanced age (&amp;gt;37 years) as the strongest negative predictor of live birth (aOR 0.36, p&amp;lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In DOR patients managed with PPOS and freeze-all, GH pretreatment improves quantitative stimulation metrics and biochemical pregnancy but does not increase clinical pregnancy or live birth. Kuntai capsule demonstrates no beneficial effects across all endpoints. These findings do not support routine use of these adjuvants in this treatment paradigm.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1897970","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:28:02Z","timestamp":1785731282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth hormone enhances ovarian response but not live births in DOR patients undergoing PPOS with freeze-all strategy: a retrospective cohort study contrasted with Kuntai capsule"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoju","family":"Wan","sequence":"first","affiliation":[{"name":"Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Wu","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Huang","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2021.09.013","article-title":"Cholesterol metabolism is decreased in patients with diminished ovarian reserve","volume":"44","author":"Yang","year":"2022","journal-title":"Reprod Biomedicine Online"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2025.105354","article-title":"Oocyte quality in women with diminished ovarian reserve: not as poor as assumed","volume":"52","author":"Yan","year":"2026","journal-title":"Reprod Biomedicine Online"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.12.093","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","year":"2020","journal-title":"Fertility Sterility"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202772","article-title":"Higher chromosomal aberration frequency in products of conception from women older than 32 years old with diminished ovarian reserve undergoing IVF\/ICSI","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12864-023-09728-0","article-title":"Diminished ovarian reserve causes adverse ART outcomes attributed to effects on oxygen metabolism function in cumulus cells","volume":"24","author":"Zhang","year":"2023","journal-title":"BMC Genomics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.fertnstert.2020.02.112","article-title":"Perinatal outcome in young patients with diminished ovarian reserve undergoing assisted reproductive technology","volume":"114","author":"Hu","year":"2020","journal-title":"Fertility Sterility"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15543","article-title":"Comparison of progestin-primed ovarian stimulation regimen and antagonist regimen in women aged 35\u2009years or older with diminished ovarian reserve: a propensity score-matched study","volume":"167","author":"Wang","year":"2024","journal-title":"Int J Gynaecol Obstetrics: Off Organ Int Fed Gynaecol Obstetrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.102049","article-title":"A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders","volume":"50","author":"Cai","year":"2021","journal-title":"J Gynecology Obstetrics Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1232935","article-title":"The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF\/ICSI: a systematic review and meta-analysis","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.702558","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: A meta-analysis of randomized controlled trials","volume":"12","author":"Guan","year":"2021","journal-title":"Front Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118167","article-title":"Kuntai capsule for the treatment of diminished ovarian reserve: A systematic review and meta-analysis of randomized controlled trials","volume":"329","author":"Zhang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4367359","article-title":"Effectiveness of cotreatment with kuntai capsule and climen for premature ovarian failure: A meta-analysis","volume":"2020","author":"Ma","year":"2020","journal-title":"Evidence-Based Complementary Altern Med eCAM"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0254-6272(17)30062-6","article-title":"Comparison of the effect and safety of Kuntai capsule and hormone replacement therapy in patients with perimenopausal syndrome: a systematic review and meta-analysis","volume":"37","author":"Du","year":"2017","journal-title":"J Traditional Chin Med = Chung I Tsa Chih Ying Wen Pan"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i28.8349","article-title":"Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function","volume":"9","author":"Lin","year":"2021","journal-title":"World J Clin cases"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/s0254-6272(17)30160-7","article-title":"Heyan Kuntai capsule versus dehydroepiandrosterone in treating Chinese patients with infertility caused by diminished ovarian reserve: a multicenter, randomized controlled trial","volume":"37","author":"Gao","year":"2017","journal-title":"J Traditional Chin Med = Chung I Tsa Chih Ying Wen Pan"},{"key":"B17","article-title":"Effect of kuntai capsule on the number of retrieved oocytes, high-quality oocytes and embryos in in vitro fertilization of poor ovarian response patients","volume":"34","author":"Lian","year":"2014","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chin J Integrated Traditional Western Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/cells10010129","article-title":"Central regulation of metabolism by growth hormone","volume":"10","author":"Donato","year":"2021","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms19010005","article-title":"Pituitary gonadotropins, prolactin and growth hormone differentially regulate AQP1 expression in the porcine ovarian follicular cells","volume":"19","author":"Skowronski","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1215755","article-title":"Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1457866","article-title":"The effects of growth hormone on the outcomes of in vitro fertilization and embryo transfer in age-grouped patients with decreased ovarian reserve: a prospective cohort study","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1551126","article-title":"The role of growth hormone in assisted reproductive technology for patients with diminished ovarian reserve: from signaling pathways to clinical applications","volume":"16","author":"Han","year":"2025","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2021.1925521","article-title":"Causal inference with multilevel data: a comparison of different propensity score weighting approaches","volume":"57","author":"Fuentes","year":"2022","journal-title":"Multivar Behav Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.803471","article-title":"Hormonal replacement treatment for frozen-thawed embryo transfer with or without GnRH agonist pretreatment: a retrospective cohort study stratified by times of embryo implantation failures","volume":"13","author":"Xia","year":"2022","journal-title":"Front Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1040503","article-title":"Growth hormone in fertility and infertility: mechanisms of action and clinical applications","volume":"13","author":"Chang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.3390\/ijms231810768","article-title":"The clinical application of growth hormone and its biological and molecular mechanisms in assisted reproduction","volume":"23","author":"Pan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00775","article-title":"The effect of growth hormone on the clinical outcomes of poor ovarian reserve patients undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment: a retrospective study based on POSEIDON criteria","volume":"10","author":"Cai","year":"2019","journal-title":"Front Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13048-023-01279-y","article-title":"Growth hormone supplementation during ovarian stimulation in women with advanced maternal age undergoing preimplantation genetic testing for aneuploidy","volume":"16","author":"Sui","year":"2023","journal-title":"J Ovarian Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00298-0","article-title":"Effects of growth hormone supplementation on poor ovarian responders in assisted reproductive technology: a systematic review and meta-analysis","volume":"28","author":"Liu","year":"2021","journal-title":"Reprod Sci (Thousand Oaks Calif)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2024.09.038","article-title":"Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials","volume":"123","author":"Conforti","year":"2025","journal-title":"Fertility Sterility"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1072313","article-title":"Regulation of ovarian function by growth hormone: potential intervention of ovarian aging","volume":"13","author":"Han","year":"2022","journal-title":"Front Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac028","article-title":"Administration of growth hormone improves endometrial function in women undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"28","author":"Shang","year":"2022","journal-title":"Hum Reprod Update"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2021.1922996","article-title":"Effect of chronological age of patients with diminished ovarian reserve on in vitro fertilization outcome","volume":"42","author":"Li","year":"2022","journal-title":"J Obstetrics Gynaecol J Institute Obstetrics Gynaecol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00327","article-title":"Impact of maternal age on oocyte and embryo competence","volume":"9","author":"Cimadomo","year":"2018","journal-title":"Front Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/gco.0000000000000536","article-title":"Diminished ovarian reserve versus ovarian aging: overlaps and differences","volume":"31","author":"Ata","year":"2019","journal-title":"Curr Opin Obstetrics Gynecology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.856667","article-title":"Abnormal BMI in male and\/or female partners are deleterious for embryonic development and pregnancy outcome during ART process: a retrospective study","volume":"13","author":"Qi","year":"2022","journal-title":"Front Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz011","article-title":"Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis","volume":"25","author":"Sermondade","year":"2019","journal-title":"Hum Reprod Update"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1897970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:28:03Z","timestamp":1785731283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1897970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":37,"alternative-id":["10.3389\/fendo.2026.1897970"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1897970","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1897970"}}